Can a single dose of ketorolac (Toradol) cause renal failure?

Can a Single Dose of Ketorolac (Toradol) Cause Renal Failure?

Yes, a single dose of ketorolac can cause acute renal failure, though this is rare and typically occurs in patients with specific risk factors. The FDA label explicitly warns that ketorolac is contraindicated in patients with advanced renal impairment and those at risk for renal failure due to volume depletion 1.

Risk Factors That Increase Vulnerability

The likelihood of renal injury after even a single dose increases substantially in patients with:

• Age ≥60 years 2
• Compromised fluid status or volume depletion 2, 1
• Pre-existing renal dysfunction (creatinine >221 μmol/L or eGFR <30 mL/min/1.73 m²) 3
• Concomitant nephrotoxic medications including ACE inhibitors, ARBs, diuretics, cyclosporine, or cisplatin 4, 2
• Heart failure or cirrhosis where renal perfusion depends on prostaglandin-mediated vasodilation 5
• Dehydration from any cause (vomiting, diarrhea, inadequate intake) 4

Mechanism and Clinical Presentation

All NSAIDs, including ketorolac, inhibit COX-2-mediated prostaglandin production that is essential for maintaining renal blood flow, particularly when perfusion is already compromised 5. This can manifest as:

• Volume-dependent acute renal failure (most common)
• Acute interstitial nephritis (AIN) - can occur even after a single dose due to prior sensitization 6
• Interstitial nephritis or papillary necrosis 2

A documented case report describes biopsy-proven AIN following a single intramuscular dose of ketorolac 6, and another case demonstrated rapidly appearing acute renal failure after one dose 7. These cases underscore that minimal exposure can trigger significant renal injury in susceptible individuals.

Monitoring and Management

If ketorolac must be used, implement the following safeguards:

• Verify baseline renal function (serum creatinine, eGFR) before administration
• Ensure adequate hydration status
• Discontinue immediately if:
  • BUN or creatinine doubles 2
  • Hypertension develops or worsens 2
  • Oliguria occurs 4

For high-risk patients requiring NSAID therapy: Consider monitoring renal function as frequently as weekly for 3 weeks after initiation, particularly if taking ACE inhibitors or ARBs concurrently 5.

Clinical Context

While systematic reviews in surgical populations (including donor nephrectomy and partial nephrectomy) found no increased risk of renal impairment with ketorolac 8, 9, these studies excluded high-risk patients. The FDA label limits ketorolac to maximum 5 days use and requires dose reduction in patients ≥65 years, <50 kg body weight, or with moderately elevated creatinine 1.

Key Pitfalls to Avoid

• Never assume safety based on "just one dose" - acute renal failure can occur after single administration 6, 7
• Do not use in volume-depleted patients - this is an absolute contraindication 1
• Avoid combining with other nephrotoxic agents - the risk compounds significantly 4, 2, 5
• Do not overlook "over-the-counter" NSAIDs - patients may already be taking ibuprofen or naproxen, creating cumulative toxicity 3

The safest approach: Avoid ketorolac entirely in patients with any of the above risk factors and use opioid analgesics as safer alternatives 2.